[contentcards url=”https://childrenshealthdefense.org/defender/fda-recommends-jn-1-covid-vaccine-cancer-risks/”] In a unanimous 16-0 vote, the U.S. Food and Drug Administration’s vaccine advisory committee today recommended a monovalent JN.1-lineage for the 2024-2025 COVID-19…

